Widespread loss of heterochromatin has been observed in tau transgenic Drosophila and mice and in human AD, and is suggested to promote tau-mediated neurodegeneration and aberrant gene expression in AD [117]. This evidence concerns the gene MAPT and Alzheimer disease.